| 000 | 01067 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517064726.0 | ||
| 264 | 0 | _c20160912 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a1558-3163 | ||
| 024 | 7 |
_a10.1016/j.rdc.2015.08.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWhittier, Xena | |
| 245 | 0 | 0 |
_aGlucocorticoid-induced Osteoporosis. _h[electronic resource] |
| 260 |
_bRheumatic diseases clinics of North America _cFeb 2016 |
||
| 300 |
_a177-89, x p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aBone Density |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aGlucocorticoids _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOsteoporosis _xchemically induced |
| 650 | 0 | 4 |
_aOsteoporotic Fractures _xchemically induced |
| 650 | 0 | 4 | _aRisk Assessment |
| 700 | 1 | _aSaag, Kenneth G | |
| 773 | 0 |
_tRheumatic diseases clinics of North America _gvol. 42 _gno. 1 _gp. 177-89, x |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.rdc.2015.08.005 _zAvailable from publisher's website |
| 999 |
_c25489967 _d25489967 |
||